Keio Innovation Initiative (KII) has invested in Feliqs, a Kyushu University startup that develops new drug discovery using a proprietary drug screening platform targeting ferotosis, from funds managed by KII. Through this capital increase, Feliqs will raise a total of approximately 300 million yen to accelerate the expansion of its business.

For more details, please see the press release.
https://prtimes.jp/main/html/rd/p/000000035.000018580.html